
Cancer's Toll Beyond the Disease: Medical Costs and Productivity
A new study published by the American Cancer Society found that younger colorectal cancer survivors end up spending over $8500 annually in medical expenses and they also experience significantly greater loss of productivity compared with individuals without cancer.
With nearly 18 million
Evaluating the impact of medical costs on survivors of 3 cancers: colorectal, female breast, and prostate, researchers from the American Cancer Society segregated the elderly and the younger population of survivors. Using data gathered by the
Young cancer survivors included in the study witnessed a significant impact of cancer on their annual medical expenses as well as on their productivity at work. Those who survived colorectal cancer had an average excess of $8647 in medical costs; breast cancer survivors, $5119; and prostate cancer survivors, $3586. Costs were relatively lower for the elderly survivors, but greater nonetheless than the comparator population: $4913 for colorectal, $2288 for breast, and $3524 for prostate.
Younger survivors of colorectal and breast cancer had significantly greater employment disability (13.6% and 4.8%, respectively) compared with those without cancer. They also lost more work days: 7.2 days on average for colorectal cancer survivors and 3.3 days for breast cancer survivors. Surprisingly, the elderly population included in the study had comparable productivity losses as those without a history of cancer in their age group.
These results indicate that survivors continue to experience disease-related symptoms even after being declared disease-free, but are forced to get back to work, likely due to monetary needs and to maintain health insurance coverage. A National Cancer Institute—funded
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.